April 14, 2023
Physics World highlighted research led by the University of Cincinnati's Nalinikanth Kotagiri that shows a proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.
March 28, 2023
Researchers led by the University of Cincinnati's Nalinikanth Kotagiri, PhD, have published new research showing proof of concept for using engineered bacteria as an adapter to deliver targeted radionuclide treatment to tumors.
April 28, 2022
Dan Hassett, PhD, a researcher in the UC Department of Molecular Genetics, Biochemistry and Microbiology, died unexpectedly Thursday, April 27. The longtime College of Medicine faculty member was 63.
January 10, 2022
UC's Dr. Nalinikanth Kotagiri was featured in a Discover Magazine article focused on the use of bacteria to fight diseases including cancer.
November 22, 2021
University of Cincinnati researchers from the College of Pharmacy were featured in a Journal-News article detailing the development of a new probiotic bacteria designed to break down cancer cell walls.
November 19, 2021
University of Cincinnati College of Pharmacy researchers have engineered a probiotic bacteria designed to break down cancer cell walls to allow therapies easier access to shrink tumors.
March 10, 2021
The University of Cincinnati has announced the inaugural class of University Research Council (URC) Faculty Scholars Research Awards to early career support of faculty researchers studying areas ranging from engineering to German studies.
October 16, 2018
Nalinikanth Kotagiri, MD, PhD, assistant professor in the James L. Winkle College of Pharmacy and a cluster hire for the Cincinnati Cancer Center, is hoping to study ways ultraviolet light can activate light-sensitive drugs to treat metastatic breast cancer.
January 12, 2017
Four of six cancer cluster hires were celebrated in an event where leadership from each of the involved colleges spoke about the momentum of this initiative moving forward.